Filing Details

Accession Number:
0001209191-21-066436
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-23 16:29:39
Reporting Period:
2021-11-22
Accepted Time:
2021-11-23 16:29:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1810182 Alx Oncology Holdings Inc ALXO Pharmaceutical Preparations (2834) 850642577
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1817127 Sophia Randolph C/O Alx Oncology Holdings Inc.
866 Malcolm Road, Suite 100
Burlingame CA 94010
Chief Medical Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-22 30,000 $4.08 179,428 No 4 M Direct
Common Stock Disposition 2021-11-22 14,884 $36.77 164,544 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-11-22 30,000 $0.00 30,000 $4.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
107,906 2030-03-09 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.54 to $37.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  2. The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.